Eagle Health Investments’s Perceptive Capital Solutions PCSC Stock Holding History

Eagle Health Investments’s Portfolio PCSC Stock Details PCSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$413K	Buy	+37,686	New	+$481K	0.07%	28

Other funds holding PCSC

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

One Fin Capital Management San Francisco, California $280M AUM 49.87% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return

Holocene Advisors

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Eagle Health Investments's PCSC Position: Q1 2026 in Review

Eagle Health Investments opened a new position in Perceptive Capital Solutions (PCSC) in Q1 2026: 37,686 shares worth $413K. The stake represents 0.07% of the portfolio and ranks #28 among its holdings.

34 funds tracked by Wall St. Rank hold PCSC as of Q1 2026.

Eagle Health Investments held 37,686 shares of Perceptive Capital Solutions worth $413K as of Q1 2026.
Perceptive Capital Solutions was a new Eagle Health Investments position in Q1 2026.
Perceptive Capital Solutions made up 0.07% of Eagle Health Investments's portfolio in Q1 2026, its #28 holding.
34 funds tracked by Wall St. Rank held Perceptive Capital Solutions as of Q1 2026.

Based on Eagle Health Investments's 13F filing for Q1 2026, filed 15 May 2026.